PDGFRB and breast carcinoma: We found that high PDGFRβ expressing basal-like breast cancer patients (n = 421) exhibited significantly higher probabilities of relapse free survival than low PDGFRβ expressing patients (n = 197) [HR = 0.77 (0.69–1); n = 618; Logrank P = 0.049].